Multibillion-dollar growth projected for global radiopharma market
An aging global population seeking care for cardiovascular, oncological and neurological disorders will drive the worldwide market for radiopharmaceuticals to more than $6.5 billion by 2017. That’s according to a Nov. 14 report from market research firm Global Industry Analysts (GIA).
The global radiopharmaceutical market, including radioactive drugs used in diagnostic and therapeutic nuclear medicine, reached $3.2 billion in 2010, according to another firm, Fast Market Research.
According to the San Jose, Calif.-based GIA, soaring demand for PET imaging will help propel the rapid growth, as will expanding product lines and increasing research efforts.
The global radiopharmaceutical market, including radioactive drugs used in diagnostic and therapeutic nuclear medicine, reached $3.2 billion in 2010, according to another firm, Fast Market Research.
According to the San Jose, Calif.-based GIA, soaring demand for PET imaging will help propel the rapid growth, as will expanding product lines and increasing research efforts.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.